Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis

ABSTRACT:

SUBMITTER: Lim W 

PROVIDER: S-EPMC10764325 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature